Beclanorsen

DB05606InvestigationalSmall molecule

Investigated for use/treatment in leukemia (lymphoid).

Primary indication
Investigated for use/treatment in leukemia (lymphoid).Curator reviewed
Code names
SPC-2996

Resolves to

Compound
UNIIZV9069GJO5CAS1072859-54-1
Targets
P10415BCL2

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Beclanorsen, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In